Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
Carvalho
M F
MF
Department of Internal Medicine, Botucatu Medical School-UNESP, São Paulo, Brazil.
Adoni
T
T
Saggioro
F P
FP
Soares
V
V
D000328:Adult; D000704:Analysis of Variance; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D017211:Treatment Failure
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone